Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We have developed recombinant fragment C based rapid point of care dipstick devices to assess tetanus immunization status using plasma or whole blood. The devices demonstrated specificity of 0.90 and sensitivity of 0.90 (whole blood)/0.94 (plasma) at field sites in Bangladesh and The Gambia when compared to a commercial ELISA with the immune cut-off titer set as ≥0.1IU/mL.

Original publication

DOI

10.1016/j.diagmicrobio.2016.11.011

Type

Journal article

Journal

Diagn Microbiol Infect Dis

Publication Date

03/2017

Volume

87

Pages

272 - 274

Keywords

Dipstick, Fragment C, Lateral flow, Tetanus, Vaccine, Adult, Antibodies, Bacterial, Bangladesh, Child, Gambia, Humans, Male, Peptide Fragments, Recombinant Proteins, Sensitivity and Specificity, Tetanus, Tetanus Toxin, Tetanus Toxoid, Vaccination